FDA
label_change
· 2007-01-09
FDA Approved: TRILEPTAL — Supplemental Application (Novartis Pharmaceuticals Corporation)
Summary
FDA approved a supplemental application for TRILEPTAL (oxcarbazepine) filed by Novartis Pharmaceuticals Corporation, likely involving a labeling change for the …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for TRILEPTAL (OXCARBAZEPINE)